SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-410030"
 

Search: onr:"swepub:oai:DiVA.org:uu-410030" > Meta-Analysis of In...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Sun, Michelle T.Univ Adelaide, South Australian Inst Ophthalmol, Adelaide, SA, Australia.;Royal Adelaide Hosp, Adelaide, SA, Australia. (author)

Meta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or Ticagrelor

  • Article/chapterEnglish2020

Publisher, publication year, extent ...

  • EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC,2020
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-410030
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-410030URI
  • https://doi.org/10.1016/j.amjcard.2020.01.012DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:for swepub-publicationtype

Notes

  • Intraocular bleeding is a devastating clinical event due to its potentially blinding nature. It is not known if determine if dual antiplatelet therapy using aspirin and potent P2Y12 inhibitors increases this risk. We searched MEDLINE and ClinicalTrials.gov for randomized controlled trials that were phase III, randomly assigned patients to dual antiplatelet therapy with either aspirin and a potent P2Y12 inhibitor or aspirin and clopidogrel, had follow-up of 6 months, and at least 200 patients. Corresponding authors were contacted for intraocular bleeding data. Inverse-variance, weighted, fixed-effects meta-analysis was undertaken, with random-effects meta-analysis performed as a sensitivity analysis. Four trials enrolling 42,850 patients were included. The median follow-up ranged from 12 to 14 months. There was overall low risk of bias. Pooled analysis demonstrated no statistically significant increase in the risk of intraocular bleeding with dual antiplatelet therapy using potent P2Y12 inhibitors compared with clopidogrel (risk ratio 0.89, 95% confidence interval 0.58 to 136). There was no significant heterogeneity observed across trials (I-2 statistic 0%, p = 0.98). The use of random-effects meta-analysis did not change the effect estimate or confidence intervals, and the results appeared similar when stratified by potent P2Y12 inhibitor (p = 0.97). In conclusion, this collaborative meta-analysis of dual antiplatelet trials does not suggest that the risk of intraocular bleeding is increased with the use of potent P2Y12 inhibitors compared with clopidogrel. Our results suggest that these potent P2Y12 inhibitors may continue to be used cautiously where indicated as part of dual antiplatelet therapy, even in those at high risk of spontaneous intraocular bleeding. Crown Copyright (C) 2020 Published by Elsevier Inc. All rights reserved.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Huang, SoniaUniv Adelaide, South Australian Inst Ophthalmol, Adelaide, SA, Australia.;Royal Adelaide Hosp, Adelaide, SA, Australia. (author)
  • Wiviott, Stephen D.Brigham & Womens Hosp, Dept Med, Cardiovasc Div, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA.;Harvard Med Sch, Boston, MA 02115 USA. (author)
  • Antman, Elliot M.Brigham & Womens Hosp, Dept Med, Cardiovasc Div, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA.;Harvard Med Sch, Boston, MA 02115 USA. (author)
  • Roe, Matthew T.Duke Univ, Duke Clin Res Inst, Sch Med, Durham, NC 27706 USA.;Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA. (author)
  • Ohman, E. MagnusDuke Univ, Duke Clin Res Inst, Sch Med, Durham, NC 27706 USA.;Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA. (author)
  • Neely, MeganDuke Univ, Duke Clin Res Inst, Sch Med, Durham, NC 27706 USA. (author)
  • Wallentin, Lars,1943-Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)(Swepub:uu)larswall (author)
  • Wong, Christopher X.Royal Adelaide Hosp, Adelaide, SA, Australia.;Univ Adelaide, Adelaide, SA, Australia. (author)
  • Univ Adelaide, South Australian Inst Ophthalmol, Adelaide, SA, Australia.;Royal Adelaide Hosp, Adelaide, SA, Australia.Brigham & Womens Hosp, Dept Med, Cardiovasc Div, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA.;Harvard Med Sch, Boston, MA 02115 USA. (creator_code:org_t)

Related titles

  • In:American Journal of Cardiology: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC125:8, s. 1280-12830002-91491879-1913

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view